Cointime update: China’s newly released national medical insurance drug list includes 51 Class 1 innovative drugs, a record high, covering oncology treatments, rare disease therapies and novel-mechanism drugs for chronic conditions. The update reflects faster R&D output being matched by stable reimbursement coverage as innovative drugs move from the lab to clinical use.
China’s 2025 Medical Insurance Drug List Adds 51 Innovative Drugs, a Record High
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
BOJ’s Ueda Says Rate Hikes Should Continue to Anchor Inflation
1h ago
South Korea’s KOSPI Turns Negative After Earlier Gaining Over 3%
2h ago
Spot silver falls 2.00% intraday to $46.44/oz, lowest since Sept 29, 2025
2h ago
Spot gold falls below $3,800/oz for first time since Sept 30
5h ago
CME FedWatch: 96.8% Odds of 25bps Fed Rate Hike in December
5h ago
US Treasury long-term buybacks fall to lowest since expansion